Alembic Pharmaceuticals Limited (APLLTD.BO)
Alembic Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vadodara, GU, IN. The stock last traded at $831.20, down 0.02% on the session, giving a market capitalisation of $163.35B. Its beta of 0.30 implies it has historically moved less than the broad market.
Established in 1907 and headquartered in Vadodara, India, Alembic Pharmaceuticals is a company dedicated to the creation, production, and sale of a diverse range of medicinal goods. Its activities span both its home country of India and international territories, with a substantial portion of its manufactured products being exported worldwide. The firm offers an extensive array of branded specialty medications, targeting numerous medical fields. These include cardiovascular health, women's health, digestive disorders, eye care, dermatological conditions, kidney and urological issues, orthopedic care, anti-infectives, common cold and cough remedies, veterinary medicine, and diabetes management. Additionally, the company develops and manufactures generic drug formulations, such as oral solids, specialized oncology products (both oral and injectable forms), general injectable medications, ophthalmic preparations, dermatological treatments, and oral suspensions. Active pharmaceutical ingredients (APIs) are also a key part of its production.
Alembic Pharmaceuticals Limited is most often compared with the following Healthcare names: